Serum metabolite signature predicts the acute onset of diabetes in spontaneously diabetic congenic BB rats

Metabolomics

Volumn 7, Issue 4, 2011, Pages 593-603

  Åkesson, Lina ^a   Trygg, Johan ^b   Fuller, Jessica M ^c   Madsen, Rasmus ^b   Gabrielsson, Jon ^d   Bruce, Stephen ^e,f   Stenlund, Hans ^b   Tupling, Terry ^c   Pefley, Ranae ^c   Lundstedt, Torbjörn ^g   Lernmark, Åke ^a,c   Moritz, Thomas ^f  

^a LUND UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c UNIVERSITY OF WASHINGTON   (United States)

^d AcureOmics AB   (Sweden)

^e NESTLÉ RESEARCH CENTER   (Switzerland)

^f SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^g AcurePharma   (Sweden)

Author keywords

Dynamic modeling; Metabolomics; OPLS DA; Type 1 diabetes

Indexed keywords

ISOLEUCINE; OLEAMIDE; PHOSPHORYLCHOLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MALE; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLITE; METABOLOMICS; NONHUMAN; ORTHOGONAL PROJECTIONS TO LATENT STRUCTURES DISCRIMINANT ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; RAT;

RATTUS;

EID: 80054042661     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-011-0278-3     Document Type: Article

References (45)

1. Akesson, L., Hawkins, T., Jensen, R., Fuller, J. M., Breslow, N. E., & Lernmark, A. (2007). Decreased core temperature and increased beta(3)-adrenergic sensitivity in diabetes-prone BB rats. Diabetes Technology & Therapeutics, 9, 354-362.
2. Akesson, L., Gelling, R. W., Jensen, R., Ogimoto, K., Fuller, J. M., Pefley, R., et al. (2008). Increased lipid oxidation heralds diabetes onset in DR. lyp/lyp rats. Experimental and Clinical Endocrinology & Diabetes, 116, 475-480. Epub 2008 May 9.
3. Baekkeskov, S., Dyrberg, T., & Lernmark, A. (1984). Autoantibodies to a 64-kilodalton islet cell protein precede the onset of spontaneous diabetes in the BB rat. Science, 224, 1348-1350.
4. Bieg, S., Simonson, W., Ellefsen, K., & Lernmark, A. (2000). Rel B is an early marker of autoimmune islet inflammation in the biobreeding (BB) rat. Pancreas, 20, 47-54.
5. Bonifacio, E., Hummel, M., Walter, M., Schmid, S., & Ziegler, A. G. (2004). IDDM1 and multiple family history of type 1 diabetes combine to identify neonates at high risk for type 1 diabetes. Diabetes Care, 27, 2695-2700.
6. Bruce, S. J., Jonsson, P., Antti, H., Cloarec, O., Trygg, J., Marklund, S. L., et al. (2008). Evaluation of a protocol for metabolic profiling studies on human blood plasma by combined ultra-performance liquid chromatography/mass spectrometry: From extraction to data analysis. Analytical Biochemistry, 372, 237-249.
7. Bylesjö, B., Rantalainen, M., Cloarec, O., Nicholson, J. K., Holmes, E., & Trygg, J. (2007). OPLS discriminant analysis, combining the strengths of PLS-DA and SIMCA classification. Journal of Chemometrics, 20, 341-351.
8. D'eon, T. M., Pierce, K. A., Roix, J. J., Tyler, A., Chen, H., & Teixeira, S. R. (2008). The role of adipocyte insulin resistance in the pathogenesis of obesity-related elevations in endocannabinoids. Diabetes, 57, 1262-1268. Epub 2008 Feb 14.
9. Diabetes Prevention Trial-Type-1 Diabetes Study Group. (2002). Effects of insulin in relatives of patients with type 1 diabetes mellitus. New England Journal of Medicine, 346, 1685-1691.
10. Eckardt, K., Sell, H., Taube, A., Koenen, M., Platzbecker, B., Cramer, A., et al. (2009). Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle. Diabetologia, 52, 664-674. Epub 2008 Dec 17.
11. Fuller, J. M., Kwitek, A. E., Hawkins, T. J., Moralejo, D. H., Lu, W., Tupling, T. D., et al. (2006). Introgression of F344 rat genomic DNA on BB rat chromosome 4 generates diabetes-resistant lymphopenic BB rats. Diabetes, 55, 3351-3357.
12. Fuller, J. M., Bogdani, M., Tupling, T. D., Jensen, R. A., Pefley, R., Manavi, S., et al. (2009). Genetic dissection reveals diabetes loci proximal to the Gimap5 lymphopenia gene. Physiological Genomics, 38(1), 89-97.
13. Gale, E. A. (2002). The rise of childhood type 1 diabetes in the 20th century. Diabetes, 51, 3353-3361.
14. Genuth, S., Alberti, K. G., Bennett, P., Buse, J., Defronzo, R., Kahn, R., et al. (2003). Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care, 26, 3160-3167.
15. Geoffrey, R., Jia, S., Kwitek, A. E., Woodliff, J., Ghosh, S., Lernmark, A., et al. (2006). Evidence of a functional role for mast cells in the development of type 1 diabetes mellitus in the BioBreeding rat. Journal of Immunology, 177, 7275-7286.
16. Gillespie, K. M., Bain, S. C., Barnett, A. H., Bingley, P. J., Christie, M. R., Gill, G. V., et al. (2004). The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet, 364, 1699-1700.
17. Hessner, M. J., Wang, X., Meyer, L., Geoffrey, R., Jia, S., Fuller, J., et al. (2004). Involvement of eotaxin, eosinophils, and pancreatic predisposition in development of type 1 diabetes mellitus in the BioBreeding rat. Journal of Immunology, 173, 6993-7002.
18. Hornum, L., Romer, J., & Markholst, H. (2002). The diabetes-prone BB rat carries a frameshift mutation in Ian4, a positional candidate of Iddm1. Diabetes, 51, 1972-1979.
19. Jackson, J. E. (1991). A user's guide to principal components. New York: John Wiley & Sons, Inc.
20. Jacob, H. J., Pettersson, A., Wilson, D., Mao, Y., Lernmark, A., & Lander, E. S. (1992). Genetic dissection of autoimmune type I diabetes in the BB rat. Nature Genetics, 2, 56-60.
21. Jonsson, P., Johansson, A. I., Gullberg, J., Trygg, J., A, J., Grung, B., et al. (2005). High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses. Analytical Chemistry, 77, 5635-5642.
22. Jonsson, P., Johansson, E. S., Wuolikainen, A., Lindberg, J., Schuppe-Koistinen, I., Kusano, M., et al. (2006). Predictive metabolite profiling applying hierarchical multivariate curve resolution to GC-MS data-a potential tool for multi-parametric diagnosis. Journal of Proteome Research, 5, 1407-1414.
23. Lamb, M. M., Yin, X., Zerbe, G. O., Klingensmith, G. J., Dabelea, D., Fingerlin, T. E., et al. (2009). Height growth velocity, islet autoimmunity and type 1 diabetes development: the Diabetes Autoimmunity Study in the Young. Diabetologia, 52, 2064-2071. Epub 2009 Jun 23.
24. Larsson, H. E., Lynch, K., Lernmark, B., Hansson, G., Lernmark, A., & Ivarsson, S. A. (2007). Relationship between increased relative birthweight and infections during pregnancy in children with a high-risk diabetes HLA genotype. Diabetologia, 50, 1161-1169. Epub 2007 Apr 4.
25. Larsson, H. E., Hansson, G., Carlsson, A., Cederwall, E., Jonsson, B., Larsson, K., et al. (2008). Children developing type 1 diabetes before 6 years of age have increased linear growth independent of HLA genotypes. Diabetologia, 51, 1623-1630. Epub 2008 Jul 1.
26. Lynch, K. F., Lernmark, B., Merlo, J., Cilio, C. M., Ivarsson, S. A., & Lernmark, A. (2008). Cord blood islet autoantibodies and seasonal association with the type 1 diabetes high-risk genotype. Journal of Perinatology, 28, 211-217. Epub 2008 Feb 14.
27. Macmurray, A. J., Moralejo, D. H., Kwitek, A. E., Rutledge, E. A., van Yserloo, B., Gohlke, P., et al. (2002). Lymphopenia in the BB rat model of type 1 diabetes is due to a mutation in a novel immune-associated nucleotide (Ian)-related gene. Genome Research, 12, 1029-1039.
28. Markholst, H., Eastman, S., Wilson, D., Fisher, L., & Lernmark, A. (1993). Decreased weight gain in BB rats before the clinical onset of insulin-dependent diabetes. Diabetes Research and Clinical Practice, 21, 31-38.
29. Mordes, J. P., Bortell, R., Blankenhorn, E. P., Rossini, A. A., & Greiner, D. L. (2004). Rat models of type 1 diabetes: genetics, environment, and autoimmunity. ILAR Journal, 45, 278-291.
30. Nejentsev, S., Sjoroos, M., Soukka, T., Knip, M., Simell, O., Lovgren, T., et al. (1999). Population-based genetic screening for the estimation of type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci. Diabetic Medicine, 16, 985-992.
31. Onengut-Gumuscu, S., & Concannon, P. (2006). Recent advances in the immunogenetics of human type 1 diabetes. Current Opinion in Immunology, 18, 634-638.
32. Oresic, M., Simell, S., Sysi-Aho, M., Nanto-Salonen, K., Seppanen-Laakso, T., Parikka, V., et al. (2008). Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. Journal of Experimental Medicine, 205, 2975-2984. Epub 2008 Dec 15.
33. Pihoker, C., Gilliam, L. K., Hampe, C. S., & Lernmark, A. (2005). Autoantibodies in diabetes. Diabetes, 54, S52-S61.
34. Rich, S. S., Akolkar, B., Concannon, P., Erlich, H., Hilner, J., Julier, C., et al. (2009). Results of the MHC fine mapping workshop. Diabetes Obesity & Metabolism, 11(Suppl 1), 108-109.
35. Schauer, N., Steinhauser, D., Strelkov, S., Schomburg, D., Allison, G., Moritz, T., et al. (2005). GC-MS libraries for the rapid identification of metabolites in complex biological samples. FEBS Letters, 579, 1332-1337.
36. Sosenko, J. M., Krischer, J. P., Palmer, J. P., Mahon, J., Cowie, C., Greenbaum, C. J., et al. (2008). A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1. Diabetes Care, 31, 528-533.
37. Stenlund, H., Madsen, R., Calderisi, M., Lundstedt, T., Tassini, M., Carmellini, M., et al. (2009). Monitoring kidney-transplant patients using metabolomics and dynamic modeling. Chemoterics and Intelligent Laboratory Systems, 98, 45-50.
38. Teddy-Study-Group. (2008). The environmental determinants of diabetes in the Young (TEDDY) study. Annals of the New York Academy of Sciences, 1150, 1-13.
39. Trygg, J., & Lundstedt, T. (2007). Handbook of metabonomics and metabolomics. Oxford: Elsevier.
40. Trygg, J., & Wold, S. (2002). Orthogonal projections to latent structures (O-PLS). Journal of Chemometrics, 116, 119-128.
41. Trygg, A., J., Gullberg, J., Johansson, A. I., Jonsson, P., Antti, H., et al. (2005). Extraction and GC/MS analysis of the human blood plasma metabolome. Analytical Chemistry, 77, 8086-8094.
42. Trygg, J., Holmes, E., & Lundstedt, T. (2007). Chemometrics in metabonomics. Journal of Proteome Research, 6, 469-479.
43. Wenzlau, J. M., Juhl, K., Yu, L., Moua, O., Sarkar, S. A., Gottlieb, P., et al. (2007). The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proceedings of the National Academy of Sciences of the United States of America, 104, 17040-17045. Epub 2007 Oct 17.
44. Wold, S. (1978a). Cross-validatory estimation of the number of components in factor and principal components models. Technometrics, 20, 397-405.
45. Wold, S. (1978b). Cross-validatory estimation of the number of components in factor and principal components models. Technometrics, 20, 397-405.